Financial Disclosure Applies To Firms Providing Drugs For Public Studies
This article was originally published in The Tan Sheet
Executive Summary
Pharmaceutical companies that contribute drugs to publicly funded studies used to support marketing applications will be responsible for collecting investigator financial interest information, an updated financial disclosure guidance notes.